WILMINGTON, NC--PPD Inc. (NASDAQ:PPDI) says it has completed a first-in-human study with its new statin for the treatment of high cholesterol. The compound was safe and well tolerated at all doses in this clinical trial.
WILMINGTON, NC--PPD Inc. (NASDAQ:PPDI) says it has completed a first-in-human study with its new statin for the treatment of high cholesterol. The compound was safe and well tolerated at all doses in this clinical trial.
